METABOLIC SYNDROME AND ITS COMPONENTS HAVE A DIFFERENT PRESENTATION AND IMPACT ON THE CARDIOVASCULAR RISK PROFILE OF PATIENTS WITH PSORIATIC AND RHEUMATOID ARTHRITIS

被引：0
|
作者：
Atzeni, F. [1 ]
La Corte, L. [1 ]
Cirillo, M. [1 ]
Giallanza, M. [1 ]
Rodriguez-Carrio, J. [2 ,3 ]
机构：
[1] Univ Messina, Dept Expt & Internal Med, Rheumatol Unit, Messina, Italy
[2] Univ Oviedo, Dept Funct Biol, Oviedo, Spain
[3] Inst Invest Sanitaria Principado Asturias ISPA, Dept Metab, Oviedo, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Comorbidities; Cardiovascular disease; Inflammatory arthritides;
D O I：
10.1136/annrheumdis-2023-eular.269
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0338
引用
收藏
页码：1352 / 1352
页数：1
相关论文
共 50 条
  • [21] Impact of treatment with infliximab on serum cytokine profile of patients with rheumatoid and psoriatic arthritis
    Amital, Howard
    Barak, Vivian
    Winkler, Robert E.
    Rubinow, Alan
    AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH, 2007, 1110 : 649 - 660
  • [22] IMPACT OF A CARDIOVASCULAR EVENT ON DMARD TREATMENT AMONG PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, OR PSORIASIS
    Sparks, J. A.
    Lesperance, T.
    Accortt, N. A.
    Solomon, D. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 114 - 114
  • [23] Risk: Benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis
    Fleischmann, Roy
    Iqbal, Imran
    DRUGS & AGING, 2007, 24 (03) : 239 - 254
  • [24] Risk: Benefit Profile of Etanercept in Elderly Patients with Rheumatoid Arthritis, Ankylosing Spondylitis or Psoriatic Arthritis
    Roy Fleischmann
    Imran Iqbal
    Drugs & Aging, 2007, 24 : 239 - 254
  • [25] Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis
    Radner, Helga
    Lesperance, Tamara
    Accortt, Neil A.
    Solomon, Daniel H.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (10) : 1510 - 1518
  • [26] INCIDENCE AND PREVALENCE OF CARDIOVASCULAR RISK FACTORS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIASIS, OR PSORIATIC ARTHRITIS
    Solomon, D. H.
    Lesperance, T.
    Radner, H.
    Accortt, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 411 - 411
  • [27] Cardiovascular risk profile of patients with psoriatic arthritis compared to controlsthe role of inflammation
    Tam, L. -S.
    Tomlinson, B.
    Chu, T. T. -W.
    Li, M.
    Leung, Y. -Y.
    Kwok, L. -W.
    Li, T. K.
    Yu, T.
    Zhu, Y. -E.
    Wong, K. -C.
    Kun, E. W. -L.
    Li, E. K.
    RHEUMATOLOGY, 2008, 47 (05) : 718 - 723
  • [28] The impact of metabolic syndrome on rheumatoid arthritis in a cohort of Egyptian patients
    Eldin, Amina B.
    ElBakry, Samah A.
    Morad, Caroline S.
    Abd-El-Samie, Aly M.
    EGYPTIAN RHEUMATOLOGIST, 2018, 40 (01): : 7 - 10
  • [29] Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis
    Peters, MJ
    van der Horst-Bruinsma, IE
    Dijkmans, BA
    Nurmohamed, MT
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2004, 34 (03) : 585 - 592
  • [30] Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis
    Nurmohamed, MT
    van Halm, VP
    Dijkmans, BAC
    DRUGS, 2002, 62 (11) : 1599 - 1609
12345